id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0519-0024,FDA,FDA-2009-N-0519,"Rosalie K. Elespuru, PhD - FDA/CDRH - Testimony",Other,TS-Testimony,2010-02-24T05:00:00Z,2010,2,2010-02-24T05:00:00Z,,2013-07-27T23:09:46Z,,0,0,0900006480aadcf9
FDA-2009-N-0519-0022,FDA,FDA-2009-N-0519,"U.S. FDA/National Center for Toxicological Research - Martha M. Moore, Ph.D. - Testimony",Other,TS-Testimony,2010-02-22T05:00:00Z,2010,2,2010-02-22T05:00:00Z,,2013-07-27T23:09:16Z,,0,0,0900006480aa8eeb
FDA-2009-N-0519-0020,FDA,FDA-2009-N-0519,FDA/CDER - Transcript,Other,TR-Transcript,2010-02-12T05:00:00Z,2010,2,2010-02-12T05:00:00Z,,2013-08-11T03:06:46Z,,0,0,0900006480a91d93
FDA-2009-N-0519-0018,FDA,FDA-2009-N-0519,"Theresa Allio, Ph.D. - FDA/CDER - Testimony",Other,TS-Testimony,2010-02-04T05:00:00Z,2010,2,2010-02-04T05:00:00Z,,2013-07-27T23:05:59Z,,0,0,0900006480a8d382
FDA-2009-N-0519-0017,FDA,FDA-2009-N-0519,"Robert H. Heflich, Ph.D. - FDA/NCTR - Testimony",Other,TS-Testimony,2010-02-04T05:00:00Z,2010,2,2010-02-04T05:00:00Z,,2013-07-27T23:05:57Z,,0,0,0900006480a8cd2f
FDA-2009-N-0519-0016,FDA,FDA-2009-N-0519,FDA/CDER - Testimony,Other,TS-Testimony,2010-01-26T05:00:00Z,2010,1,2010-01-26T05:00:00Z,,2013-08-11T01:32:12Z,,0,0,0900006480a82fd1
FDA-2009-N-0519-0013,FDA,FDA-2009-N-0519,CDER Genetic Toxicology Subcommittee - Memorandum,Other,M-Memorandum,2010-01-25T05:00:00Z,2010,1,2010-01-25T05:00:00Z,,2013-08-11T01:32:11Z,,0,0,0900006480a82033
FDA-2009-N-0519-0012,FDA,FDA-2009-N-0519,CDER Genetic Toxicology Subcommittee - Memorandum,Other,M-Memorandum,2010-01-25T05:00:00Z,2010,1,2010-01-25T05:00:00Z,,2013-07-27T23:04:59Z,,0,0,0900006480a81f35
FDA-2009-N-0519-0011,FDA,FDA-2009-N-0519,CDER Genetic Toxicology Subcommittee - Memorandum,Other,M-Memorandum,2010-01-25T05:00:00Z,2010,1,2010-01-25T05:00:00Z,,2013-07-27T23:04:59Z,,0,0,0900006480a81f31
FDA-2009-N-0519-0007,FDA,FDA-2009-N-0519,FDA - Background,Other,BKG-Background Material,2010-01-15T05:00:00Z,2010,1,2010-01-15T05:00:00Z,,2013-07-27T23:04:26Z,,0,0,0900006480a7d731
FDA-2009-N-0519-0006,FDA,FDA-2009-N-0519,FDA - Background,Other,BKG-Background Material,2010-01-15T05:00:00Z,2010,1,2010-01-15T05:00:00Z,,2013-07-27T23:04:26Z,,0,0,0900006480a7d72f
FDA-2009-N-0519-0008,FDA,FDA-2009-N-0519,Dan Levy (CFSAN) - Testimony,Other,TS-Testimony,2010-01-15T05:00:00Z,2010,1,2010-01-15T05:00:00Z,,2013-07-27T23:04:18Z,,0,0,0900006480a7c7bb
FDA-2009-N-0519-0002,FDA,FDA-2009-N-0519,FDA - Background,Other,BKG-Background Material,2010-01-13T05:00:00Z,2010,1,2010-01-13T05:00:00Z,,2013-08-11T01:32:00Z,,0,0,0900006480a7ca78
FDA-2009-N-0519-0005,FDA,FDA-2009-N-0519,FDA - Background,Other,BKG-Background Material,2010-01-13T05:00:00Z,2010,1,2010-01-13T05:00:00Z,,2013-07-27T23:04:20Z,,0,0,0900006480a7ca7f
FDA-2009-N-0519-0003,FDA,FDA-2009-N-0519,FDA - Background,Other,BKG-Background Material,2010-01-13T05:00:00Z,2010,1,2010-01-13T05:00:00Z,,2013-07-27T23:04:11Z,,0,0,0900006480a7bbf8
FDA-2009-N-0519-0004,FDA,FDA-2009-N-0519,FDA - Background,Other,BKG-Background Material,2010-01-13T05:00:00Z,2010,1,2010-01-13T05:00:00Z,,2013-08-11T03:06:13Z,,0,0,0900006480a7a869
FDA-2009-N-0519-0001,FDA,FDA-2009-N-0519,Public Workshop: International Conference on Harmonisation S2 Genetic Toxicology Issues; Request for Comments,Notice,NM-Notice of Meeting,2009-11-03T05:00:00Z,2009,11,2009-11-03T05:00:00Z,2010-02-25T04:59:59Z,2009-11-03T18:30:17Z,E9-26397,0,0,0900006480a4fe9e